FDA Recalls Weight Loss Product Containing Undeclared Sibutramine and Phenolphthalein
Lucy's Weight Loss System is recalling Shorts on The Beach Golden Edition because it contains undeclared sibutramine and phenolphthalein.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of 5 according to the rubric.
Plain-English summary
Lucy's Weight Loss System (dba. Waisted With Lucy) is recalling Shorts on The Beach Golden Edition by Pink Bikini, 800 mg, packaged in 30-count plastic bottles. The product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
The recall was initiated because the product contains undeclared sibutramine and phenolphthalein. These ingredients were not listed on the product label. The recall covers all lots of the product.
The product was distributed nationwide. Consumers who have this product should stop using it and contact the manufacturer for further instructions.
The recalled product
- Product
- Shorts on The Beach Golden Edition by Pink Bikini, 800 mg, packaged in 30-count plastic bottle, Manufactured and Distributed by: Lucy's Weight Loss System, Arlington, Texas 76010
- Manufacturer
- Lucy's Weight Loss (dba. Waisted With Lucy)
- Category
- Drug — Weight Loss Supplement
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Lucy's Weight Loss (dba. Waisted With Lucy) under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Lucy's Weight Loss (dba. Waisted With Lucy)
See all →- CriticalShorts on the Beach capsules recalled for undeclared dangerous ingredients
FDA (Drugs) · 2016-06-01
- CriticalPink Bikini capsules recalled for undeclared dangerous ingredients
FDA (Drugs) · 2016-06-01
- CriticalPink Bikini Strong Formula capsules recalled for undeclared ingredients
FDA (Drugs) · 2016-06-01
- CriticalFDA Recalls Weight Loss Capsules Containing Undeclared Sibutramine and Phenolphthalein
FDA (Drugs) · 2016-06-01
Same hazard · undeclared ingredients
See all →- CriticalFDA Recalls Addall XR Shot Liquid Dietary Supplement
FDA (Food) · 2026-09-02
- SevereD'Dioses Mango Ice Pops Recalled for Undeclared Allergens
FDA (Food) · 2026-07-22
- ModerateSuper ProTHIN Plus Dietary Supplement Recalled for Undeclared Dyes
FDA (Food) · 2025-07-02
- LowGaiser's Recalls Ready-to-Eat Bologna Due to Undeclared Meat Ingredients
USDA FSIS · 2025-06-27
- HighFlour tortillas recalled due to undeclared wheat allergen
FDA (Food) · 2024-05-29
Similar recalls
- CriticalShorts on the Beach capsules recalled for undeclared dangerous ingredients
FDA (Drugs) · 2016-06-01
- CriticalPink Bikini capsules recalled for undeclared dangerous ingredients
FDA (Drugs) · 2016-06-01
- CriticalFDA Recalls LaBri's Body Health Atomic 60 Capsules for Sibutramine Contamination
FDA (Drugs) · 2017-12-27
- CriticalAkttive Fat Burner Recalled for Undeclared Dangerous Ingredients
FDA (Drugs) · 2016-02-24
- CriticalDietary Supplement Recalled for Undeclared Sibutramine and Lack of Approval
FDA (Drugs) · 2014-09-24
- CriticalFDA Recalls Unapproved Weight Loss Pills Containing Undeclared Phenolphthalein
FDA (Drugs) · 2014-06-18